Ed Neas, Ph.D.


Dr. Neas has been with Armis Biopharma® since 1998 as a founder and creator of the company’s technology platform when the company was originally Chata Biosystems, Inc. Chata’s technology assets of a patented packaging system for chemical delivery to analytical instruments used in pharmaceutical quality assurance laboratories, have since been sold.

Previously Dr. Neas was the Director of R&D and Quality Assurance for Summit Biotechnology (1994-1997), a wholly owned subsidiary of ConAgra Corporation. Prior to this Dr. Neas served as part owner and Vice President of R&D at Rubbright Corporation, a small biotech consulting company (1983-1992). Before that Dr. Neas held the position of principal scientist and head of research involved in development of new products at CEM Corporation, now a large corporation developing microwave based technology for analytical chemistry. Dr. Neas began his career as Director of R&D for the development of new products at HyClone Laboratories (1981-1983) now owned by GE Healthcare Life Sciences and Thermo Scientific.

Dr. Neas received his bachelor and master’s degrees from Texas A&M, Kingsville Texas, in microbiology, with minors in chemistry, and his Ph.D. from Utah State University in microbiology. Dr. Neas is one of the inventors on eighteen issued patents, 24 pending applications, and 3 new Armis Biopharma® provisional applications.